Atai Life Sciences Operating Income 2020-2024 | ATAI
Atai Life Sciences operating income from 2020 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Atai Life Sciences Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-125 |
| 2022 | $-145 |
| 2021 | $-136 |
| 2020 | $-104 |
| 2019 | $-18 |
| Atai Life Sciences Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-23 |
| 2024-06-30 | $-26 |
| 2024-03-31 | $-24 |
| 2023-12-31 | $-34 |
| 2023-09-30 | $-27 |
| 2023-06-30 | $-32 |
| 2023-03-31 | $-33 |
| 2022-12-31 | $-38 |
| 2022-09-30 | $-38 |
| 2022-06-30 | $-35 |
| 2022-03-31 | $-33 |
| 2021-12-31 | $-45 |
| 2021-09-30 | $-33 |
| 2021-06-30 | $-61 |
| 2021-03-31 | $4 |
| 2020-12-31 | $-87 |
| 2020-09-30 | $-7 |
| 2020-06-30 | $-6 |
| 2020-03-31 | $-4 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.200B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $19.704B | 11.92 |
| Quest Diagnostics (DGX) | United States | $16.912B | 17.14 |
| DaVita (DVA) | United States | $12.098B | 15.65 |
| Encompass Health (EHC) | United States | $9.453B | 22.29 |
| Chemed (CHE) | United States | $7.853B | 24.14 |
| Elanco Animal Health (ELAN) | United States | $5.843B | 13.91 |
| RadNet (RDNT) | United States | $5.284B | 117.02 |
| Option Care Health (OPCH) | United States | $3.848B | 18.23 |
| Amedisys (AMED) | United States | $2.744B | 19.53 |
| LifeStance Health (LFST) | United States | $2.698B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.350B | 27.57 |
| Astrana Health (ASTH) | United States | $1.974B | 26.99 |
| U.S Physical Therapy (USPH) | United States | $1.380B | 36.27 |
| Pennant (PNTG) | United States | $0.938B | 37.92 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.873B | 0.00 |
| Bioqual (BIOQ) | United States | $0.059B | 0.00 |
| Daxor (DXR) | United States | $0.039B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |